WO2025083627 - NOVEL CRYSTALLINE FORMS OF MITAPIVAT SULFATE AND PROCESSES FOR PREPARATION
National phase entry is expected:
Publication Number
WO/2025/083627
Publication Date
24.04.2025
International Application No.
PCT/IB2024/060258
International Filing Date
18.10.2024
Title **
[English]
NOVEL CRYSTALLINE FORMS OF MITAPIVAT SULFATE AND PROCESSES FOR PREPARATION
[French]
NOUVELLES FORMES CRISTALLINES DE SULFATE DE MITAPIVAT ET PROCÉDÉS DE PRÉPARATION ASSOCIÉS
Applicants **
APITORIA PHARMA PRIVATE LIMITED
Inventors
KOREPU, Padma
MUPPALLA, Siva Rama Krishna
NASIR, Ali
NEELA, Praveen Kumar
Priority Data
202341071009
18.10.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1955 | |
| EPO | Filing, Examination, Granting | 11624 | |
| Japan | Filing, Examination, Granting | 2016 | |
| South Korea | Filing, Examination, Granting | 1788 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
22,723
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to novel polymorphs of Mitapivat sulfate, designated as crystalline Mitapivat sulfate Form MIP-1 and MIP-2 and processes for the preparation thereof.[French]
La présente invention concerne de nouveaux polymorphes de sulfate de mitapivat, désignés en tant que formes cristallines de sulfate de mitapivat MIP-1 et MIP-2, et leurs procédés de préparation.